Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+3.06M
-
Total reported value, excl. options
-
$1.18B
-
Value change
-
+$118M
-
Put/Call ratio
-
0.85
-
Number of buys
-
78
-
Number of sells
-
-84
-
Price
-
$32.40
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2015
219 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q4 2015.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 79.5M outstanding shares and own 45.69% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.17M shares), VANGUARD GROUP INC (2.05M shares), FMR LLC (1.93M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.87M shares), WADDELL & REED FINANCIAL INC (1.85M shares), Sectoral Asset Management Inc (1.59M shares), STATE STREET CORP (1.52M shares), WELLS FARGO & COMPANY/MN (1.47M shares), PUTNAM INVESTMENTS LLC (1.45M shares), and BB BIOTECH AG (1.3M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.